December 8, 2020

Intellectual Property with Tim Worden and Duncan Greenhalgh of Goodwin

Goodwin and Arctoris present a five-part webinar series where we lay the foundation for successfully establishing a biotech company. The path from target identification to IND, into the clinic and towards approval is full of challenges. Knowing what lies ahead, and learning about financial, legal, organisational, personal and scientific requirements enables researchers to successfully translate their findings into potential new treatments for patients.

The fourth webinar in the Arctoris Masterclass series covers relevant, protectable IP is at the heart of any new biotech company. Getting it right can mean the difference between success and failure
View the Video